WASHINGTON– As far as cellular processes go, mitosis seems like a natural target for cancer drugs. "Its major business is cell growth," Genentech Inc.'s Peter Jackson told the audience at the annual meeting of the American Association for Cancer Research (AACR). It's got kinases – lots of kinases. And there is a "vast array" of traditional chemotherapies that hits some aspect of the cell cycle.